CASEY T WEAVER, MD
Medical Practice at 19 St, Birmingham, AL

License number
Alabama 16800
Category
Medical Practice
Type
Anatomic Pathology
Address
Address
619 19Th St SOUTH, Birmingham, AL 35233
Phone
(205) 934-6600
(205) 731-9701

Personal information

See more information about CASEY T WEAVER at radaris.com
Name
Address
Phone
Casey Weaver, age 53
449 Winkles Rd, Grant, AL 35747
Casey Weaver
544 County Road 4210, Crane Hill, AL 35053
(256) 747-6991
Casey Weaver, age 53
17 Bearden Dr, Grant, AL 35747
(256) 728-8905
Casey T Weaver, age 67
213 La Prado Cir, Homewood, AL 35209
(205) 538-7457
(205) 879-7981
(205) 879-2576
(205) 879-6144
Casey Weaver
115 Bonita Dr, Homewood, AL 35209
(205) 879-7981

Organization information

See more information about CASEY T WEAVER at bizstanding.com

University Alabama at Birmingham - Casey T Weaver MD

845 19 St S #870, Birmingham, AL 35205

Categories:
Physicians & Surgeons
Site:
Phone:
(205) 975-5537 (Phone)

Professional information

Casey T Weaver Photo 1

Dr. Casey T Weaver, Birmingham AL - MD (Doctor of Medicine)

Specialties:
Anatomic Pathology
Address:
845 19Th St S SUITE 13, Birmingham 35205
(205) 975-5537 (Phone), (205) 975-8310 (Fax)
1802 6Th Ave S, Birmingham 35233
619 19Th St S, Birmingham 35233
(205) 934-6600 (Phone)
UNIVERSITY OF ALABAMA HOSPITAL
619 19Th St S, Birmingham 35233
(205) 934-9999 (Phone), (205) 975-9694 (Fax)
Certifications:
Anatomic Pathology, 1994
Awards:
Healthgrades Honor Roll
Languages:
English
Hospitals:
845 19Th St S SUITE 13, Birmingham 35205
1802 6Th Ave S, Birmingham 35233
619 19Th St S, Birmingham 35233
UNIVERSITY OF ALABAMA HOSPITAL
619 19Th St S, Birmingham 35233
University of Alabama Hospital
1802 6Th Ave South, Birmingham 35233
Education:
Medical School
University Of Florida College Of Medicine
Graduated: 1984
Barnes Jewish Hospital S Campus


Casey T Weaver Photo 2

Casey T Weaver, Birmingham AL

Specialties:
Pathology, Anatomic Pathology
Work:
Uab Hospital
1802 6Th Ave S, Birmingham, AL 35249 Birmingham Va Medical Center
700 19Th St S, Birmingham, AL 35233
Education:
University of Florida (1984)


Casey Weaver Photo 3

Pathway For Th-17 Cell Development And Methods Utilizing Same

US Patent:
2010020, Aug 12, 2010
Filed:
Oct 16, 2009
Appl. No.:
12/580926
Inventors:
Casey T. Weaver - Birmingham AL, US
Paul R. Mangan - Doylestown PA, US
Laurie E. Harrington - Birmingham AL, US
Assignee:
THE UAB RESEARCH FOUNDATION - Birmingham AL
International Classification:
A61K 38/20, A61K 39/395, A61K 38/16, A61K 31/7088, A61K 38/21, A61P 37/04
US Classification:
424 852, 4241581, 514 12, 514 44 R, 424 855, 424 857
Abstract:
The present disclosure demonstrates for the first time that Th-17 cells are the product of a distinct CD4 T cell lineage with unique developmental and functional characteristics. The developmental signals required for Th-17 commitment and development are also described. As a result, the teachings of the present disclosure provide a basis for understanding the developmental pathway of Th-17 cells and offer novel avenues to modulate (stimulate or inhibit) this developmental program and offer new methods for the treatment and prevention of disease states and conditions related to aberrant activity of Th-17 cells.


Casey Weaver Photo 4

Pathway For Th-17 Cell Development And Methods Utilizing Same

US Patent:
8414897, Apr 9, 2013
Filed:
Oct 2, 2007
Appl. No.:
11/866380
Inventors:
Casey T. Weaver - Birmingham AL, US
Paul R. Mangan - Doylestown PA, US
Laurie E. Harrington - Birmingham AL, US
Assignee:
The UAB Research Foundation - Birmingham AL
International Classification:
A61K 39/395
US Classification:
4241581, 4241301
Abstract:
The present disclosure demonstrates for the first time that Th-17 cells are the product of a distinct CD4 T cell lineage with unique developmental and functional characteristics. The developmental signals required for Th-17 commitment and development are also described. As a result, the teachings of the present disclosure provide a basis for understanding the developmental pathway of Th-17 cells and offer novel avenues to modulate (stimulate or inhibit) this developmental program and offer new methods for the treatment and prevention of disease states and conditions related to aberrant activity of Th-17 cells.